✦ LIBER ✦

An Economic Evaluation of Adjuvant Trastuzumab Therapy in HER2-Positive Early Breast Cancer

✍ Scribed by Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen

Book ID: 109079086
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 60 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2009.00634.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Cost Utility of Sequential Adjuvant Tras

Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer

✍ Shelby D. Reed; Kevin A. Schulman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Transferability of Model-Based Economic

Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

✍ Brigitte A.B. Essers; Shanley C. Seferina; Vivianne C.G. Tjan-Heijnen; Johan L. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Should adjuvant trastuzumab be offered i

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate

✍ Fausto Petrelli; Sandro Barni 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 210 KB

Adjuvant trastuzumab with chemotherapy i

Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer

✍ Heather L. McArthur; Kathleen M. Mahoney; Patrick G. Morris; Sujata Patil; Linds 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 1 views

## Abstract ## BACKGROUND: Several large, randomized trials established the benefits of adjuvant trastuzumab with chemotherapy. However, the benefit for women with small, node‐negative HER2‐positive (HER2+) disease is unknown, as these patients were largely excluded from these trials. Therefore, a